Chikungunya infected children are being reported these days, said Dr. Deepal Perera, a specialist at the Lady Ridgeway ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

Cases of Chikungunya among children are being reported in recent days, Lady Ridgeway Hospital’s Consultant Paediatrician Dr. Deepal Perera said. Dr.

BENGALURU: Vaccines and antiviral, although not very effective are there for flu virus, however there are none which are clinically approved for mosquito borne ...

Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...

This action follows an executive order signed by President Trump on his first day in office to withdraw the United States ...

Seventy-two case have been diagnosed as confirmed GBS cases and 20 patients are currently on ventilators, it said. So far, ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Two deaths and 16 fresh suspected cases of Guillain-Barré Syndrome (GBS) were reported in Pune and other districts, the ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, ...

Bhopal: AIIMS Bhopal department of microbiology has secured NABL accreditation. The department stands out for having two NABL ...